These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 4015733)
1. Pharmacological and toxicological properties of ryodipine. Kimenis AA; Vitolina RO; Petersone IO; Germane SK; Briede JL Arzneimittelforschung; 1985; 35(4):672-9. PubMed ID: 4015733 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466). Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734 [TBL] [Abstract][Full Text] [Related]
3. Acute and subacute toxicity of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)-1 ,4-dihydropyridine (PP-1466). Gomi T; Yamamoto H; Ozeki M; Fujikura M; Hirao A; Kobayashi M; Tateishi T; Yumoto S; Okumura M; Aikawa K Arzneimittelforschung; 1985; 35(6):915-22. PubMed ID: 4026916 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Yamaura T; Kase N; Kita H; Uematsu T Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142 [TBL] [Abstract][Full Text] [Related]
5. [General pharmacologic studies on the analgesic flupirtine]. Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator. Baldoli E; Bianchi G; Corsico N; Di Francesco GF Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties. Zwagemakers JM; Claassen V Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021 [TBL] [Abstract][Full Text] [Related]
8. Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria. Velena AH; Dubur GJ; Vitolina RO; Kimenis AA; Selga MJ; Zarinsh GV; Narusevicius EV; Macianskiene RA; Gendvilienè VI; Simkhovich BZ Arzneimittelforschung; 1985; 35(6):907-14. PubMed ID: 2992533 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M; Schiavi P; Vincent M; Schmitt H J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [TBL] [Abstract][Full Text] [Related]
10. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
12. General pharmacology of the new antimuscarinic compound vamicamide. Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs. Osada E; Murai T; Ishizaka Y; Sanai K Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157 [TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil. Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578 [TBL] [Abstract][Full Text] [Related]
15. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of ryodipine in rats. Parinov VJ; Odinec AG; Gilev AP; Dubur GJ; Muceniece DH; Ozol JJ; Shatz VD; Gavars MP; Vigante BA Arzneimittelforschung; 1985; 35(5):808-13. PubMed ID: 4026904 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies of the antihypertensive effect of nitrendipine. Stoepel K; Heise A; Kazda S Arzneimittelforschung; 1981; 31(12):2056-61. PubMed ID: 7199297 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. Jolly SR; Hardman HF; Gross GJ J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies with quazepam, a new benzodiazepine hypnotic. Ongini E; Parravicini L; Bamonte F; Guzzon V; Iorio LC; Barnett A Arzneimittelforschung; 1982; 32(11):1456-62. PubMed ID: 6129857 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of a new antihypertensive agent in several species. Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]